AdvanSix (ASIX) Q3 2026 Earnings Call Transcript

AdvanSix (ASIX) reported Q3 2026 sales of $431M, up 15% YoY, driven by pricing. Adjusted EBITDA was $15M, down $10M YoY. Ammonia sales expected to rise 25% for the year. Nylon resin production up 5% YoY. Company focuses on cost reduction, operational excellence, and disciplined capital deployment.

Original reporting
Published Nov 4, 2026, 7:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 7:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AdvanSix (ASIX) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ASIXBearishMed
01

Why it matters

The earnings release offers fresh data on revenue growth, cost structure, and cash flow, informing short‑term trading decisions.

02

Market read

Earnings data may trigger modest price movement; investors will focus on margin trends and guidance.

03

What to watch

Potential upside from 45Q carbon capture tax credits and upcoming DEF growth project not fully priced in.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

AdvanSix provided its Q3 2026 earnings call, outlining operational performance, cost pressures, and strategic initiatives.

Company-level read

Ticker impact

$ASIXBearishHigh confidence
Context

Q3 2026 earnings call disclosed revenue of $431M, adjusted EBITDA $15M and EPS loss of $0.24, the first public release of these figures.

Expected impact

likely modest downside as investors weigh lower EBITDA against revenue growth

Evidence & confidence

Earnings beat on revenue but miss on profitability; guidance unchanged, so limited upside.

Market effects

Signals continued pressure on chemical intermediates sector margins amid raw material cost volatility.

North American chemical producers may see similar cost‑pass‑through dynamics.

Limited; primarily relevant to investors in specialty chemicals and related supply chains.

Counterpoint

Despite margin pressure, the 25% rise in ammonia sales and carbon‑credit runway could support upside.

Key entities

  • AdvanSix

    Specialty chemicals producer reporting Q3 2026 results.

Related articles

Med

AdvanSix Inc. Q3 2026 Earnings Call Summary

AdvanSix Inc. reported Q3 2026 earnings, highlighting 17% favorable pricing offsetting $65M raw material cost increases. The company maintained high operating rates, optimized production, and reduced fixed costs. It expects Q4 price-over-raws headwinds and a 2027 ammonium sulfate supply shortage. AdvanSix secured a $47M USDA grant for Project CENTURY and closed a $425M credit facility.

$ASIXHigh

AdvanSix stock slips 2% on third quarter earnings miss

AdvanSix Inc. (ASIX) reported Q3 earnings that missed expectations, with an adjusted loss per share of -$0.24 vs. $0.28 estimate. Revenue was $430.81M, up 15% YoY. Stock fell 2% in pre-market trading. The company cited strong commercial execution and pricing strategies to offset inflation. Adjusted EBITDA declined to $14.6M, while cash flow improved to $48M. ASIX refinanced its credit facility and declared a $0.16 quarterly dividend.

$ASIXHigh

ADVANSIX ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS

AdvanSix Inc. (ASIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release ADVANSIX ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS 3Q26 Sales of $431 million, up 15% versus prior year 3Q26 Earnings Per Share of ($0.28); Adjusted Earnings Per Share of ($0.24) 3Q26 Cash Flow from Operations of $48 million, up $21 million versus p